Monurol (Fosfomycin Trometamol) Pricing and Guidelines

USANZ Members may be interested in the following information distributed by Mayne Pharma.

Following a recent Therapeutic Guidelines update, Monurol (Fosfomycin Trometamol) is a first line option for the treatment of acute cystitis.

Monurol is the only single dose antibiotic available for the treatment of uncomplicated UTIs in appropriate females above 12 years of ago. 

A significant revision of empirical treatment for urinary tract infections was recently published. The updated Australian guidelines are now in line with the European Association of Urology (EAU) and the Infectious Diseases Society of America (IDSA); Monurol is a first-line choice for UTI treatment. This reflects the local resistance patterns and supports the appropriate use of antibiotics.

The cost to patients is approximately $45.